D Imberti

Summary

Affiliation: Hospital of Piacenza
Country: Italy

Publications

  1. doi request reprint Interventional treatment of venous thromboembolism: a review
    Davide Imberti
    Department of Internal Medicine, Piacenza Hospital, Italy
    Thromb Res 129:418-25. 2012
  2. pmc Prophylaxis of venous thromboembolism with low molecular weight heparin in bariatric surgery: a prospective, randomised pilot study evaluating two doses of parnaparin (BAFLUX Study)
    Davide Imberti
    Thrombosis Centre, Internal Medicine Department, Piacenza Hospital, Via Taverna 49, 29100, Piacenza, Italy
    Obes Surg 24:284-91. 2014
  3. doi request reprint Prevention of venous thromboembolism in acutely ill medical patients after the results of recent trials with the new oral anticoagulants
    Davide Imberti
    Internal Medicine Department, Haemostasis and Thrombosis Center, Piacenza Hospital, Via Taverna 49, 29121, Piacenza, Italy
    Intern Emerg Med 8:667-72. 2013
  4. doi request reprint Emergency reversal of anticoagulation with vitamin K antagonists with 3-factor prothrombin complex concentrates in patients with major bleeding
    D Imberti
    Ospedale Civile, Piacenza, Italy
    J Thromb Thrombolysis 36:102-8. 2013
  5. doi request reprint Interventional approaches in VTE treatment (vena cava filters, catheter-guided thrombolysis, thrombosuction)
    Davide Imberti
    Department of Internal Medicine, Piacenza Hospital, Via Taverna 49, Piacenza, Italy
    Semin Respir Crit Care Med 33:176-85. 2012
  6. doi request reprint Therapeutic potential of apixaban in the prevention of venous thromboembolism in patients undergoing total knee replacement surgery
    Davide Imberti
    Department of Internal Medicine, Piacenza Hospital, Via Taverna 49, 29121, Piacenza, Italy
    J Thromb Thrombolysis 34:208-13. 2012
  7. doi request reprint Retrievable vena cava filters: a clinical review
    Davide Imberti
    Department of Internal Medicine, Piacenza Hospital, Via Taverna 49, 29121 Piacenza, Italy
    J Thromb Thrombolysis 33:258-66. 2012
  8. pmc D-dimer testing: advantages and limitations in emergency medicine for managing acute venous thromboembolism
    D Imberti
    Intern Emerg Med 2:70-1. 2007
  9. doi request reprint Treatment of venous thromboembolism in patients with cancer: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)
    Davide Imberti
    Emergency Department, Piacenza Hospital, Italy
    Thromb Res 124:e32-40. 2009
  10. doi request reprint Pharmacodynamics of low molecular weight heparin in patients undergoing bariatric surgery: a prospective, randomised study comparing two doses of parnaparin (BAFLUX study)
    Davide Imberti
    Ospedale Civile, Piacenza, Italy
    Thromb Res 124:667-71. 2009

Detail Information

Publications36

  1. doi request reprint Interventional treatment of venous thromboembolism: a review
    Davide Imberti
    Department of Internal Medicine, Piacenza Hospital, Italy
    Thromb Res 129:418-25. 2012
    ..Moreover, the appropriate indications for their use in daily clinical practice are reviewed...
  2. pmc Prophylaxis of venous thromboembolism with low molecular weight heparin in bariatric surgery: a prospective, randomised pilot study evaluating two doses of parnaparin (BAFLUX Study)
    Davide Imberti
    Thrombosis Centre, Internal Medicine Department, Piacenza Hospital, Via Taverna 49, 29100, Piacenza, Italy
    Obes Surg 24:284-91. 2014
    ..The aim of this multicentre, open-label, pilot study was to evaluate the efficacy and safety of two different doses of the LMWH parnaparin administered to patients undergoing bariatric surgery...
  3. doi request reprint Prevention of venous thromboembolism in acutely ill medical patients after the results of recent trials with the new oral anticoagulants
    Davide Imberti
    Internal Medicine Department, Haemostasis and Thrombosis Center, Piacenza Hospital, Via Taverna 49, 29121, Piacenza, Italy
    Intern Emerg Med 8:667-72. 2013
    ..However, a better risk stratification of patients who have a persistently increased risk of VTE is warranted to improve the risk to benefit profile of any anticoagulant drug to be used in this setting...
  4. doi request reprint Emergency reversal of anticoagulation with vitamin K antagonists with 3-factor prothrombin complex concentrates in patients with major bleeding
    D Imberti
    Ospedale Civile, Piacenza, Italy
    J Thromb Thrombolysis 36:102-8. 2013
    ..3-factor PCC administration is an effective, rapid ad safe treatment for the urgent reversal of VKAs in patients with acute major bleeding. Broader use of PCC in this clinical setting appears to be appropriate...
  5. doi request reprint Interventional approaches in VTE treatment (vena cava filters, catheter-guided thrombolysis, thrombosuction)
    Davide Imberti
    Department of Internal Medicine, Piacenza Hospital, Via Taverna 49, Piacenza, Italy
    Semin Respir Crit Care Med 33:176-85. 2012
    ....
  6. doi request reprint Therapeutic potential of apixaban in the prevention of venous thromboembolism in patients undergoing total knee replacement surgery
    Davide Imberti
    Department of Internal Medicine, Piacenza Hospital, Via Taverna 49, 29121, Piacenza, Italy
    J Thromb Thrombolysis 34:208-13. 2012
    ..This review focuses the clinical efficacy and tolerability of oral apixaban for the prevention of VTE in adult patients following TKR surgery...
  7. doi request reprint Retrievable vena cava filters: a clinical review
    Davide Imberti
    Department of Internal Medicine, Piacenza Hospital, Via Taverna 49, 29121 Piacenza, Italy
    J Thromb Thrombolysis 33:258-66. 2012
    ..Moreover, the appropriate indications for their use in daily clinical practice are reviewed...
  8. pmc D-dimer testing: advantages and limitations in emergency medicine for managing acute venous thromboembolism
    D Imberti
    Intern Emerg Med 2:70-1. 2007
  9. doi request reprint Treatment of venous thromboembolism in patients with cancer: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)
    Davide Imberti
    Emergency Department, Piacenza Hospital, Italy
    Thromb Res 124:e32-40. 2009
    ..The treatment of venous thromboembolism (VTE) in cancer patients remains controversial...
  10. doi request reprint Pharmacodynamics of low molecular weight heparin in patients undergoing bariatric surgery: a prospective, randomised study comparing two doses of parnaparin (BAFLUX study)
    Davide Imberti
    Ospedale Civile, Piacenza, Italy
    Thromb Res 124:667-71. 2009
    ..The optimal dose of low-molecular-weight-heparin (LMWH) to prevent venous thromboembolism (VTE) after bariatric surgery remains controversial...
  11. doi request reprint Venous thromboembolism prevention in patients with heart failure: an often neglected issue
    Davide Imberti
    Dipartimento di Emergenza, Centro Emostasi e Trombosi, Medicina Interna Area Critica, Guglielmo da Saliceto Hospital, Piacenza, Italy
    Pathophysiol Haemost Thromb 36:69-74. 2008
    ....
  12. doi request reprint Successful protein C concentrate administration during initiation of oral anticoagulation in adult patients with severe congenital protein C deficiency: report of two cases
    Davide Imberti
    Thrombosis and Haemostasis Center, Emergency Department, Piacenza Hospital, Piacenza, Italy
    Pathophysiol Haemost Thromb 36:53-7. 2008
    ..We conclude that PC concentrate seems to be effective for the prevention of thromboembolic complications and safe in patients with congenital PC deficiency while initiating oral anticoagulants...
  13. doi request reprint Clinical characteristics and management of cancer-associated acute venous thromboembolism: findings from the MASTER Registry
    Davide Imberti
    Thrombosis Center Emergency Department, Piacenza Hospital, Via Taverna 49, 29100 Piacenza, Italy
    Haematologica 93:273-8. 2008
    ..The aim of this paper was to provide information on clinical characteristics and management of acute venous thromboembolism in patients with cancer by means of a large prospective registry...
  14. ncbi request reprint Retrievable vena cava filters: key considerations
    D Imberti
    Thrombosis Center, Emergency Department, Hospital of Piacenza, Italy
    Thromb Res 122:442-9. 2008
    ..Large prospective cohort studies or randomized trials are strongly warranted to definitely clarify the beneficial role of these devices...
  15. doi request reprint Prothrombin complex concentrates for urgent anticoagulation reversal in patients with intracranial haemorrhage
    D Imberti
    Ospedale Civile, Piacenza, Italy
    Pathophysiol Haemost Thromb 36:259-65. 2008
    ..Prothrombin complex concentrates (PCCs) produce a rapid and effective reversal of OAT effects, but little evidence exists on their efficacy and safety in the management of ICH in patients on OAT...
  16. ncbi request reprint [Antithrombin: prospects in clinical practice. Sespsi: anticoagulant or anti-inflammatory agents?]
    D Imberti
    Ambulatorio Trombosi, III Unità Operativa di Medicina Interna, Ospedale Civile di Piacenza, Piacenza, Italy
    Minerva Anestesiol 69:371-5. 2003
    ....
  17. ncbi request reprint Safety and efficacy of enoxaparin treatment in venous thromboembolic disease during acute leukemia
    Davide Imberti
    Third Internal Medicine Unit and Medical Oncology and Haematology, Civic Hospital, Piacenza, Italy
    Tumori 90:390-3. 2004
    ..The best treatment of this complication is still a matter of debate due to the very high risk of hemorrhage in this group of patients...
  18. ncbi request reprint Clinical experience with retrievable vena cava filters: results of a prospective observational multicenter study
    D Imberti
    Department of Internal Medicine, Ospedale Civile, Piacenza, Italy
    J Thromb Haemost 3:1370-5. 2005
    ..Retrievable inferior vena cava (IVC) filters offer the attractive possibility to be definitive or to be removed when they become unnecessary...
  19. ncbi request reprint Venous thromboembolism prophylaxis in medical patients: future perspectives
    Davide Imberti
    Thrombosis Center, Deparment of Internal Medicine, Hospital of Piacenza, Piacenza, Italy
    Thromb Res 116:365-75. 2005
    ..Although new evidence represents a significant improvement both in stratification of VTE risk and in decisions about the appropriate type and duration of prophylactic strategies in medical patients, additional data are still needed...
  20. ncbi request reprint Management of primary care patients with suspected deep vein thrombosis: use of a therapeutic dose of low-molecular-weight heparin to avoid urgent ultrasonographic evaluation
    D Imberti
    Emergency Department, Thrombosis Center, Hospital of Piacenza, Via Taverna 49, 29100 Piacenza, Italy
    J Thromb Haemost 4:1037-41. 2006
    ..The accuracy of clinical prediction rules in the primary care setting may be inadequate, D-dimer testing may not be available, and the cost-effectiveness of urgent ultrasonographic evaluation is uncertain...
  21. ncbi request reprint A survey of thromboprophylaxis management in patients with major trauma
    Davide Imberti
    Department of Internal Medicine, Piacenza Hospital, Piacenza, Italy
    Pathophysiol Haemost Thromb 34:249-54. 2005
    ..We tested the hypothesis that there is significant practice variation in thromboprophylaxis management of patients with major trauma among intensive care unit (ICU) specialists...
  22. ncbi request reprint Retrievable vena cava filters: a review
    Davide Imberti
    Thrombosis Center, Emergency Department, Hospital of Piacenza, Piacenza, Italy
    Curr Opin Hematol 13:351-6. 2006
    ..To examine the current literature regarding retrievable inferior vena cava filters and to discuss the appropriate indications for their clinical use...
  23. doi request reprint The short- and long-term risk of venous thromboembolism in patients with acute spinal cord injury: a prospective cohort study
    M Giorgi Pierfranceschi
    Emergency Department, Hospital of Piacenza, Via Taverna 49, Piacenza 29121, Italy
    Thromb Haemost 109:34-8. 2013
    ..In conclusion, the risk of VTE in patients suffering from SCI is high despite the use of thromboprophylaxis, in particular in some patients categories. However, this risk appears to be limited to the first 3 months after the index event...
  24. ncbi request reprint Low-molecular-weight heparins: before or after surgery? New concepts and evidence: Congress report from the Sigma Tau/ROVI Satellite Symposium (Rome, Italy, 13 November 2006)
    Eduardo Rocha
    School of Medicine, Haematology Service, University Clinic of Navarra, University of Navarra, Pamplona, Spain
    Clin Drug Investig 27:357-66. 2007
    ..This article highlights presentations given during that symposium...
  25. ncbi request reprint Extended oral anticoagulant therapy after a first episode of pulmonary embolism
    Giancarlo Agnelli
    Sezione di Medicina Interna e Cardiovascolare, Dipartimento di Medicina Interna, Universita di Perugia, Via Enrico Dal Pozzo, 06123 Perugia, Italy
    Ann Intern Med 139:19-25. 2003
    ..The optimal duration of oral anticoagulant treatment after a first episode of pulmonary embolism remains uncertain...
  26. ncbi request reprint Prophylaxis and treatment of venous thromboembolism in patients with cancer: an update
    Michela Falciani
    Department of Critical Care Medicine and Surgery, University of Florence, Florence, Italy
    Intern Emerg Med 1:273-8. 2006
    ..The presence of a tumour is often associated with thrombotic complications that are more difficult to diagnose, and sometimes make the treatment of VTE less effective and more likely to cause haemorrhages...
  27. ncbi request reprint Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients
    Melina Verso
    Sezione di Medicina Interna e Cardiovascolare, Dipartimento di Medicina Interna, Universita di Perugia, Via Enrico Dal Pozzo, 06123 Perugia, Italy
    J Clin Oncol 23:4057-62. 2005
    ..The aim of this study was to evaluate the efficacy and safety of the low molecular weight heparin, enoxaparin, in the prevention of VTE...
  28. ncbi request reprint [Prophylaxis and treatment of venous thromboembolism: the role of new antithrombotic drugs]
    Michela Falciani
    Centro Trombosi, Dipartimento di Area Critica Medico Chirurgica, Azienda Ospedaliera Universitaria Careggi, Firenze
    Recenti Prog Med 96:196-204. 2005
    ..Ximelagatran, the first orally available thrombin inhibitor, represents a promising new anticoagulant drug for the prophylaxis of VTE after major orthopedic surgery and for the treatment of deep vein thrombosis...
  29. ncbi request reprint Epidemiology and risk factors of venous thromboembolism
    Walter Ageno
    Department of Clinical Medicine, University of Insubria, Varese, Italy
    Semin Thromb Hemost 32:651-8. 2006
    ..The presence or absence of specific risk factors may play an important role in decisions about the type (and duration) of thromboprophylaxis/anticoagulation to be used...
  30. ncbi request reprint Factors associated with the timing of diagnosis of venous thromboembolism: results from the MASTER registry
    Walter Ageno
    U O Medicina I, Ospedale di Circolo, University of Insubria, Varese, Italy
    Thromb Res 121:751-6. 2008
    ..We aimed to evaluate the timing of diagnosis of deep vein thrombosis (DVT) and pulmonary embolism (PE) in Italian hospitals and to identify individual and clinical predictors of timely or delayed diagnosis...
  31. ncbi request reprint The MASTER registry on venous thromboembolism: description of the study cohort
    Giancarlo Agnelli
    Division of Internal and Cardiovascular Medicine Stroke Unit, University of Perugia, Via Gerardo Dottori, 06100, Perugia, Italy
    Thromb Res 121:605-10. 2008
    ..The aim of this multicenter registry (MASTER) was to prospectively collect data on the epidemiology and long-term clinical outcome of VTE in an unselected cohort of patients...
  32. ncbi request reprint A prospective study on cardiovascular events after acute pulmonary embolism
    Cecilia Becattini
    Sezione di Medicina Interna e Cardiovascolare, Dipartimento di Medicina Interna, Universita di Perugia, Via Enrico Dal Pozzo, 06126 Perugia, Italy
    Eur Heart J 26:77-83. 2005
    ..To evaluate the incidence of cardiovascular events in the long-term clinical course of patients with a first episode of symptomatic, objectively confirmed pulmonary embolism...
  33. ncbi request reprint A survey of thrombosis prophylaxis use in patients with lower limb fractures
    Walter Ageno
    Thromb Haemost 92:1166-7. 2004
  34. ncbi request reprint A commentary: to screen for calf DVT or not to screen? The highly variable practice among Italian centers highlights this important and still unresolved clinical option. Results from the Italian MASTER registry
    Gualtiero Palareti
    Thromb Haemost 99:241-4. 2008
  35. ncbi request reprint Retrievable vena cava filters: clinical experience
    Francesco Dentali
    Department of Clinical Medicine, University of Insubria, Varese, Italy
    Curr Opin Pulm Med 12:304-9. 2006
    ..To summarize currently available literature regarding indications for inferior vena cava filters, potential problems associated with the different filters available, and the efficacy and safety of retrievable inferior vena cava filters...
  36. doi request reprint Serial 2-point ultrasonography plus D-dimer vs whole-leg color-coded Doppler ultrasonography for diagnosing suspected symptomatic deep vein thrombosis: a randomized controlled trial
    Enrico Bernardi
    Department of Emergency and Accident Medicine, Civic Hospital, Conegliano, Italy
    JAMA 300:1653-9. 2008
    ..No randomized comparisons are yet available evaluating the relative values of these 2 strategies...